The company
POMDOCTOR LIMITED - Class A
POM · Nasdaq
POM stood above a rising 150-day average in 0 of the last 19 weekly readings. It is 25.1% above that average now. Retail — Specialty: 27% of its 106 stocks in an uptrend (+2 points in four weeks); Consumer Discretionary: 26% (+2 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 19
- Industry in uptrend
- 27% +2 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 6 (-3)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 19 weeks.
Retail — Specialty: A minority of its stocks are in an uptrend and the share has held steady. Consumer Discretionary: A minority of its stocks are in an uptrend and the share has held steady.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| CITADEL ADVISORS LLCreduced · filed 14 Aug 2026 | 21,273$31K | -343,330−94.2% |
| UBS Group AGreduced · filed 13 Aug 2026 | 3,463$5,021 | -13,180−79.2% |
| Caitong International Asset Management Co., Ltdreduced · filed 5 Aug 2026 | 893$1,295 | -30,692−97.2% |
| Arax Advisory Partnersnew · filed 10 Aug 2026 | 722$1,047 | +722 |
| Steward Partners Investment Advisory, LLCreduced · filed 13 Aug 2026 | 111$161 | -1,889−94.4% |
| RHUMBLINE ADVISERSreduced · filed 12 Aug 2026 | 41$60 | -709−94.5% |
News
No headline names it lately.
Everyone who traded it
Nobody on record has traded it.
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.